Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project (APOF)

January 7, 2014 updated by: Jordi Gol i Gurina Foundation

Efficiency Program Monitoring and Control of Hypertension Through Pharmacy Offices. APOF Project

Background: Hypertension in adults is the factor most prevalent cardiovascular risk and motivates further inquiries, generating a very high cost of medical care.

Objective: To evaluate the monitoring of well-controlled hypertensive patients Pharmacy Offices. Hypothesis: the monitoring of these patients through the Office of Pharmacy will be as effective in obtaining good control of blood pressure as it is to obtained through health centers. Design: Multicenter randomized controlled trial along one year of follow up. Location: the city of Cerdanyola del Vallès (Barcelona). Participants: All patients diagnosed with hypertension and good control criteria in the past year. Arms: Health centers (control) and Pharmacy Offices (intervention). Outcome variable: blood pressure under good control along the monitoring

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

677

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Cerdanyola del Valllés, Barcelona, Spain, 08290
        • Institut Català de la Salut (ICS)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age not less than 18 years
  • HTA controlled over 2 years of evolution
  • Subjects with a history open to participating health centers or stable residence in the geographic area
  • Subjects who agree to participate

Exclusion Criteria:

  • Comorbidity and concomitant (Diabetes Mellitus, Heart failure or renal failure
  • Patients with temporary residence in the geographic area of study
  • Subjects of hypertension controlled by outside professionals to our primary care teams.
  • Subjects with home care or any other cause which does not permit their displacement, transfer to the clinic or pharmacy during the evaluation period.
  • Subjects with severe diseases of poor prognosis, hopefully less than one year of life.
  • Subjects who do not have telephones.
  • Subjects with communication problems (cognitive impairment, sensory, language barrier)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Health Center (usual practice)
Controlling arterial pressure in the health center (a common practice is carried out)
Experimental: Collaboration of pharmacies
Pharmacies cooperate in Measurement of Arterial Pressure of patients
Pharmacies cooperate in measuring blood pressure of patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of hypertensive patients with criteria for good control of their arterial pressure along one year follow up
Time Frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010)
We considered as a for good control criterion , obtaining values of systolic arterial pressure to below 140 mm Hg and diastolic blood pressure below 90 mm Hg dea, held along the entire the year follow-up of patients
Monitoring of patients for 12 months (from January 1 to December 31, 2010)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reduction in the number of visits to the health center to measure blood pressure
Time Frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010)
The number of visits to the health center where blood pressure is measured. We hope that the number of visits to the health center where blood pressure is measured is lower in the intervention group (the patients have the option to go to the pharmacy to carrying out checks blood pressure)
Monitoring of patients for 12 months (from January 1 to December 31, 2010)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Oscar Solans, G Physician, Institut Català de la Salut (Spain)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

December 23, 2013

First Submitted That Met QC Criteria

January 7, 2014

First Posted (Estimate)

January 10, 2014

Study Record Updates

Last Update Posted (Estimate)

January 10, 2014

Last Update Submitted That Met QC Criteria

January 7, 2014

Last Verified

January 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Measurement of Arterial Pressure

3
Subscribe